XML 85 R37.htm IDEA: XBRL DOCUMENT v3.25.1
SEGMENT INFORMATION (Tables)
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The table below details the Company’s revenues, significant expenses, and other segment items and reconciles those amounts to the Company’s consolidated net loss as computed under U.S. GAAP in the Consolidated Statements of Operations:
Year Ended December 31,
20242023
Revenues$57,800 $176,232 
Less:
Research and development70,289 108,497 
General and administrative37,827 45,322 
Clinical manufacturing operations35,345 97,697 
Impairment of long-lived assets5,521 65,528 
Impairment of goodwill and indefinite-lived intangible assets— 89,485 
Stock-based compensation12,382 27,363 
Other segment items (*)
(5,623)171 
Net loss$(97,941)$(257,831)
(*) Other segment items include restructuring charges, interest and other income, net, and income tax benefit.